Woodcock: FDA plans guidance to address new COVID-19 variants

Woodcock: FDA plans guidance to address new COVID-19 variants

Source: 
RAPS.org
snippet: 

The US Food and Drug Administration is actively monitoring and assessing how current vaccines, therapeutics, and diagnostics are impacted by emerging COVID-19 variants and will issue guidance for ongoing medical product development against these variants.